The purpose of this research study is to evaluate the safety and tolerability following a single IV dose of IBI314 administered to ambulatory adult patients with COVID-19.
In order to determine if you pre-qualify for this research study, we are going to ask you some confidential questions about your health history and present condition.
You do not have to answer any questions that make you uncomfortable and you may stop this interview at any time. Do we have your permission to proceed?